Premium
P4‐334: DIFFERENTIAL ASSOCIATION BETWEEN CANCER INCIDENCE RISK AND ALZHEIMER'S DISEASE ACCORDING TO DEMENTIA MEDICATION
Author(s) -
Ye Byoung Seok,
Choi Seong H.,
Kim EunJoo
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.07.104
Subject(s) - medicine , dementia , vascular dementia , hazard ratio , cancer , confidence interval , incidence (geometry) , population , disease , cohort , physics , optics , environmental health
associated with a 2.5 hazard ratio for death (Table 1a). EQ-VAS proxy-rated health for the patient was a stronger predictor of mortality and a dose-effect was evident. Patients with EQ-VAS proxy-rated health below 50 were 9 times more likely to die within three years than those whose scores were above 80. Patients with scores between 50 and 80 had a fourfold increase in risk of dying compared to those with scores above 80 (Table 1b). Conclusions: The study identified EQ-VAS self-rated health and proxy-rated health as early and strong predictors of three-year mortality for patients with mild dementia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom